Principal Investigator
GlaxoSmithKline
Xiaodan Ji is a Principal Investigator in the Drug Substance Process Development Department at GSK, Upper Merion. She holds a PhD in Molecular and Cell Biology, during which she worked on receptor tyrosine kinase in cancer cell proliferation and survival. After that, she was Postdoctoral Fellows at UC Berkeley and the University of Pennsylvania, working on the molecular mechanisms in cancer progression and metastasis. Xiaodan has co-authored over 10 research papers. Since joining GSK, she has been working on various biopharma projects including cell line development for mAbs and enzymes, implement of flow cytometry technology in bioprocess monitoring, developing upstream continuous perfusion process using ATF technology.